Biomarker Type: Proteomic
-
Validation of a High-Specificity Blood Autoantibody Test to Detect Lung Cancer in Pulmonary Nodules
-
Lung cancer associated autoantibody responses are detectable years before clinical presentation
-
Molecular and Translational Biology of the Blood-Based VeriStrat Proteomic Test Used in Cancer Immunotherapy Treatment Guidance
-
Real World Impact of a Blood Based Integrated Classifier on the Management of Benign Solid, Part Solid and Ground Glass Pulmonary Nodules
-
Comparison of a high specificity blood-based biomarker with FDG-PET for identifying malignant pulmonary nodules
-
Real World Efficacy Of First-Line Immunotherapy With Or Without Chemotherapy In Advanced NSCLC Stratified By Serum Proteomics
-
Use Of A Blood-Based Biomarker May Expedite Diagnosis Of Malignant Nodules By Supporting Biopsy
-
Using a Blood Biomarker to Distinguish Benign From Malignant Pulmonary Nodules
-
Impact of an integrated classifier using biomarkers, clinical and imaging factors on clinical decisions making for lung nodules
-
Assessing a biomarker’s ability to reduce invasive procedures in patients with benign lung nodules: Results from the ORACLE study